Senores Pharmaceuticals Ltd

NSE: SENORES · BSE: 544319 · Pharmaceuticals & Biotechnology · 13 announcements

Share price: ₹1,355.20
Market cap: ₹6,241 Cr
Revenue (annual): ₹632.6 Cr
Net profit (annual): ₹115.4 Cr
P/E (TTM): 49.4×Sector 50.4×
Promoter holding: 45.82%+0.00% QoQ
FII holding: 6.62%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 2 Annual General Meeting 2 Price Movement Clarification 1 Other Announcement 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

25 Sep 2026 16:50 IST BSE

Annual General Meeting

Senores Pharmaceuticals Annual General Meeting

Senores Pharmaceuticals held its 9th Annual General Meeting on September 25, 2026. Shareholders approved financial statements, director appointments, and the new Employee Stock Option Scheme 2026.

Read the filing ↗

3 Sep 2026 16:57 IST BSE

Annual General Meeting

Senores Pharmaceuticals Annual General Meeting

Senores Pharmaceuticals Ltd submitted its Annual Report for FY 2025-26 and notice for its 9th Annual General Meeting scheduled for September 25, 2026.

Read the filing ↗